Skip to main content
Clinical Trials/NCT03399591
NCT03399591
Unknown
Not Applicable

Correlation Between Gait Disorders and Neuropsychological Profile in Patients With Alzheimer's Disease and Lewy Body Disease

University Hospital, Strasbourg, France1 site in 1 country100 target enrollmentMay 2, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gait Disorders, Neurologic
Sponsor
University Hospital, Strasbourg, France
Enrollment
100
Locations
1
Primary Endpoint
walking test
Last Updated
7 years ago

Overview

Brief Summary

The prevalence of neurodegenerative diseases will increase over the next decades driven by ageing population. It seems important to develop reliable, replicable and accessible diagnostic tools.

This is a prospective study whose objective is to study the spatio-temporal parameters of gait in patients with Alzheimer's and Lewy body diseases. 64 patients were included in this study. A comparison of the two pathologies was conducted, followed by an analysis based on four groups (mild, severe Alzheimer's disease, mild, severe Lewy body disease) and a study of the severity of the diseases. To study these parameters, we used the Gaitrite treadmill.

The analysis of spatio-temporal parameters of walking in Alzheimer's disease and Lewy body disease enables to identify discriminating variables between the two pathologies. The probability of suffering from an Alzheimer's disease decreases with the pace increase but increases with variations in length of the step, and with the rotation of the foot. While the probability of suffering from Lewy body disease increases with the pace, variations in the step duration, and the duration of double support.

These results are interesting but do not allow to establish a diagnostic score for these two diseases. The monitoring of the variations of these parameters at individual level would probably be more relevant and would enable to detect dual pathologies.

Registry
clinicaltrials.gov
Start Date
May 2, 2017
End Date
March 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient over 50
  • Hospitalized patient in day hospital
  • Patient with an etiological diagnosis of his cognitive disorder
  • Patient having a neuropsychological assessment
  • Patient able to walk without technical help
  • Patient having agreed to participate in the study

Exclusion Criteria

  • Refusal to participate in the study

Outcomes

Primary Outcomes

walking test

Time Frame: 1 hour after inclusion

Study Sites (1)

Loading locations...

Similar Trials